Draft edition of Japanese Pharmacopoeia includes 33 new approved pharmaceutical products

Thirty-three pharmaceuticals will be added to the 18th edition of the Japanese Pharmacopoeia, if the draft edition of the official compendium of government approved medicines is finalized, as expected.

The 33 new products include antibiotics, excipients and biologics, as well as a range of crude drugs. Their expected inclusion in the Pharmacopeia, the official standard listing of pharmaceuticals approved for use in Japan by the Pharmaceuticals and Medical Devices Agency, means they are deemed safe, effective, and useful for medical care and treatment in the country.

The Pharmacopoeia, first published in 1877, is generally revised every five years. The last edition was released in 2016 and the new edition is scheduled for release next June.